Osteoarthritis
-
Recon
The single protein injection which could replace the need for knee surgery for osteoarthritis sufferers
By SARA MALM – September 3, 2016 A single injection of protein harvested from a patient’s own blood may replace the…
Read More » -
Biologics
Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain
DURHAM, N.C.–(BUSINESS WIRE)– August 9, 2016 Bioventus, a global leader in orthobiologic solutions, today announced it has launched GELSYN-3™, a…
Read More » -
Spine
Researchers discover two biomarkers that contribute to spinal osteoarthritis
5th August 2016 A research team at the Krembil Research Institute (Toronto, Canada) has discovered a pair of tissue biomarkers…
Read More » -
Recon
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
WATERTOWN, Mass. and NEW YORK, Aug. 01, 2016 (GLOBE NEWSWIRE) — pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development…
Read More » -
Hospitals
Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan
June 27, 2016 SAN DIEGO & TOKYO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that the use of Cytori…
Read More » -
Extremities
Risk of Work Time Loss Almost Double for Osteoarthritis Sufferers
TORONTO, March 24, 2016 (GLOBE NEWSWIRE) — Osteoarthritis (OA) sufferers have almost twice the risk of losing work time due…
Read More » -
Hospitals
Anika Therapeutics Announces Health Canada Approval of CINGAL® for the Treatment of Pain Associated with Osteoarthritis of the Knee
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary…
Read More » -
Hospitals
Cartiva Announces GMP Certification by Brazil’s ANVISA
(Alpharetta, GA, October 26, 2015) – Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and…
Read More » -
Recon
Ember Therapeutics Announce Initial Positive Results From a Phase 2 Trial of BMP-7 in Patients with Moderate Osteoarthritis of the Knee
NEW YORK, Oct. 19, 2015 /PRNewswire/ — Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis,…
Read More » -
Biologics
Bioventus Launches SUPARTX FX™ Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis
Bioventus Launches SUPARTZ FX™Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis DURHAM, NC – October 12,…
Read More » -
Recon
HTO combined with abrasion and microfracture seen as effective for medial OA, varus malalignment
By Monica Jaramillo High tibial osteotomy along with chondral resurfacing is efficacious for patients with severe medial osteoarthritis and varus…
Read More » -
Extremities
TKA may effectively treat post-traumatic OA after tibial plateau fracture
By Casey Tingle Total knee arthroplasty can be an effective treatment for patients with post-traumatic osteoarthritis following tibial plateau fractures,…
Read More » -
Hospitals
FLEXION THERAPEUTICS GRANTED FAST TRACK STATUS BY THE FDA FOR FX006 FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE
BURLINGTON, MASS., September 01, 2015 – Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced that the U.S. Food and Drug Administration (FDA)…
Read More » -
Extremities
Health Watch: Knee replacements common, effective
By Dr. Joseph Mannino By the time we reach age 50 and older, many of us begin to suffer knee…
Read More »